Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, March 03, 2021
Pharmaron Beijing has entered into a definitive agreement to acquire Allergan Biologics Limited in Liverpool, UK, for US$118.7 million in cash from AbbVie.
read more
Wednesday, March 03, 2021
Camargo Pharmaceutical Services will acquire Paidion Research, a global pediatric CRO based in Durham, N.C.
read more
CN Bio has received a grant from Innovate UK, the UK’s innovation agency, to develop human-relevant MPS to advance investigations into SARS-CoV-2 infection.
read more
Sinocompound Catalysts has announced the construction of a new production plant in Tongling, Anhui Province, China.
read more
ERS Genomics has announced the signing of a license agreement with Otsuka Pharmaceutical.
read more
The FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the COVID-19 pandemic.
read more
Ashland completed the expansion of its Viatel bioresorbable polymer manufacturing site and has relocated R&D from Dublin to the National Science Park, Ireland.
read more
Sharp, part of UDG Healthcare, has appointed Ria Rhemrev-Boom as its new lead EU Qualified Person (QP) for market release services.
read more
GBG and its CRO arm GD3 has acquired the Berkeley-based CRO Integrated Analytical Solutions.
read more
Novartis announced Shannon Thyme Klinger, Chief Legal Officer, has decided to resign from Novartis and return to the US to take an executive role at a biotechnology company.
read more
Aptamer Group, developer of Optimer™ reagents and therapeutics, has announced the extension of their current agreement with AstraZeneca, a global biopharmaceutical company.
read more
Debiopharm announced the signature of an exclusive license agreement with Merck KGaA, Darmstadt, Germany for the development and commercialization of xevinapant.
read more
Tergus Pharma has announced the hiring of Heather N. Sugrue as VP of Business Development.
read more
Vectura Group announced an expansion of its dry powder inhaler (DPI) development and manufacturing capabilities at its facility in Chippenham, U.K.
read more
Nonacus announced the commercial launch of a new service for Whole Genome Sequencing of SARS-CoV-2, developed to enable the UK government’s Test-To-Release scheme.
read more